| 5501 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 5502 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
68 |
| 5503 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
28 |
| 5504 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 5505 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
67 |
| 5506 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
51 |
| 5507 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5508 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
42 |
| 5509 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
55 |
| 5510 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5511 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
59 |
| 5512 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5513 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
69 |
| 5514 |
Apheresis |
Allogeneic |
Osteomyelofibrosis – Other |
Hematology |
2019 |
Standard Therapy |
Poland |
63 |
| 5515 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
70 |
| 5516 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5517 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
50 |
| 5518 |
Apheresis |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria (Pnh) |
Hematology |
2019 |
Standard Therapy |
Poland |
24 |
| 5519 |
Apheresis |
Allogeneic |
Plasma Cell Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
35 |
| 5520 |
Apheresis |
Allogeneic |
Polycythemia Vera-Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Germany |
58 |
| 5521 |
Apheresis |
Allogeneic |
Post–Polycythemia Vera Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Germany |
70 |
| 5522 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
65 |
| 5523 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5524 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
69 |
| 5525 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
64 |
| 5526 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5527 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
57 |
| 5528 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5529 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
67 |
| 5530 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
78 |
| 5531 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2019 |
Standard Therapy |
Poland |
21 |
| 5532 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2019 |
Standard Therapy |
Poland |
19 |
| 5533 |
Apheresis |
Allogeneic |
Primary Mediastinal |
Hematology |
2019 |
Standard Therapy |
Poland |
33 |
| 5534 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
46 |
| 5535 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
45 |
| 5536 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Germany |
55 |
| 5537 |
Apheresis |
Allogeneic |
Relapsed Peripheral T Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5538 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
59 |
| 5539 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
64 |
| 5540 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
60 |
| 5541 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia At Myeloproliferative Neoplasms |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5542 |
Apheresis |
Autologous |
Secondary Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
66 |
| 5543 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2019 |
Standard Therapy |
Poland |
12 |
| 5544 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2019 |
Standard Therapy |
Poland |
11 |
| 5545 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2019 |
Standard Therapy |
Poland |
55 |
| 5546 |
Apheresis |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2019 |
Standard Therapy |
Poland |
1 |
| 5547 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
44 |
| 5548 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
55 |
| 5549 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
59 |
| 5550 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
67 |
| 5551 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
45 |
| 5552 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
72 |
| 5553 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
61 |
| 5554 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
61 |
| 5555 |
Apheresis |
Autologous |
Testicular Cancer Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
29 |
| 5556 |
Apheresis |
Allogeneic |
Thalassemia Major |
Hematology |
2019 |
Standard Therapy |
Poland |
20 |
| 5557 |
Apheresis |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
1 |
| 5558 |
Apheresis |
Allogeneic |
Β – Thalassemia |
Hematology |
2019 |
Standard Therapy |
Poland |
13 |
| 5559 |
Adipose Tissue |
Autologous |
Chondromalacia |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
48,8 |
| 5560 |
Adipose Tissue |
Autologous |
Chondromalacia |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
38,6 |
| 5561 |
Adipose Tissue |
Autologous |
Coxarthrosis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
34 |
| 5562 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5563 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5564 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5565 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5566 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5567 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5568 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5569 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5570 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5571 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5572 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5573 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5574 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5575 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5576 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5577 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5578 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5579 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5580 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5581 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5582 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5583 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5584 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5585 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
44,11 |
| 5586 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
65,3 |
| 5587 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
68,6 |
| 5588 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
36,1 |
| 5589 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
54,3 |
| 5590 |
Adipose Tissue |
Autologous |
Mild Arthritis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
21,2 |
| 5591 |
Adipose Tissue |
Autologous |
Mild Arthritis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
68,5 |
| 5592 |
Adipose Tissue |
Autologous |
Osteoarthritis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
52,8 |
| 5593 |
Adipose Tissue |
Autologous |
Osteoarthritis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
44,8 |
| 5594 |
Adipose Tissue |
Autologous |
Osteoarthritis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
52,5 |
| 5595 |
Adipose Tissue |
Autologous |
Osteoarthritis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
54,5 |
| 5596 |
Adipose Tissue |
Autologous |
Osteoarthritis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
55,11 |
| 5597 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5598 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5599 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5600 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |